Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice

Overview of attention for article published in Immunologic Research, March 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 956)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 10 news outlets
blogs: 2 blogs
twitter: 99 X users

wikipedia: 4 Wikipedia pages
video: 1 YouTube creator

Citations

dimensions_citation: 61 Dimensions

Readers on

mendeley: 114 Mendeley

Summary News Blogs X Wikipedia YouTube Dimensions citations

So far, Altmetric has seen 11 news stories from 10 outlets.

Novavax: The Party’s Over

NASDAQ, 16 Apr 2022

Novavax (NVAX) lost the COVID vaccine race to Moderna and Pfizer. Profits are only now starting to roll in.

Video jab optionHaven’t yet been vaccinated for COVID? Novavax might change your mind

7News, 15 Feb 2022

This story first appeared on The Conversation. After significant delays in production and approval, Novavax – the first protein-b…

News story from Big News Network on Tuesday 15 February 2022

Big News Network, 15 Feb 2022

MIL-Evening Report: Haven’t yet been vaccinated for COVID? Novavax might change your mind

Foreign Affairs New Zealand, 15 Feb 2022

– By Jack Feehan, Research Officer – Immunology and Translational Research, Victoria University After significant delays in…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 7 additional news stories.